Quercetin and the gut-brain axis: Microbiome modulation, neuroprotection, and therapeutic implications

i

This article has been updated. A Correction to this article was published on .

i

The Original Article was published on

i

The Original Article was published on

i

This article has been updated

i

This article was retracted on

i

This article has been updated

Abstract

Quercetin is one of the dietary flavonols found mostlyin fruits and vegetables and is known to modulate the bidirectional communication among the gut microbiota, immune system, and central nervous system. Apart from its antioxidant and anti-inflammatory effects, it modulates gut microbial composition, the intestinal barrier, and neuroimmune pathways. Clinical translation is constrained because of low systemic bioavailability, extensive first-pass metabolism, and inter-individual variability caused by genetics and microbiome diversity. While nano delivery systems, phospholipid complexes, and metabolic co-administration have been proposed to improve absorption, the extent to which these interventions alter microbiota-mediated effects and yield measurable neurological outcomes in humans remains limited and requires further validation in well-controlled human studies. The evidence also supports a hormetic response, whereby moderate doses stimulate the body’s adaptive defenses, whereas supra-physiological doses may have adverse effects. Therefore, researchers should focus on standardized human trials that include neurofunctional outcomes, cerebrospinal fluid biomarkers, and multi-omics approaches to clarify the associated mechanisms. In this review, we synthesize molecular, preclinical, and clinical evidence to advance a conceptual framework that elucidates the potential of this compound as a microbiota-modulating agent, principally on mechanistic and preclinical grounds, while clinical confirmation of its therapeutic efficacy in neuropsychiatric and neurodegenerative disorders remains limited. It emphasizes the significance of gut-level interactions and microbiota-derived metabolites rather than systemic bioavailability alone.

Keywords

gut microbiota / quercetin / precision nutrition / gut-brain axis / neuroprotection / neuroinflammation / microbiota modulation

CHANGE HISTORY

A Correction to this paper has been published:
https://doi.org

The Retraction Note was updated to reflect reception of statements of disagreement from all authors.

This article has been retracted.Please see the Retraction Notice for more detail:
https://doi.org

References

[1] Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol 11: 25. https://doi.org/10.3389/fendo.2020.00025

[2] Huang TT, Lai JB, Du YL, et al. (2019) Current understanding of gut microbiota in mood disorders: An update of human studies. Front Genet 10: 98. https://doi.org/10.3389/fgene.2019.00098

[3] Shiadeh SMJ, Chan WK, Rasmusson S, et al. (2025) Bidirectional crosstalk between the gut microbiota and cellular compartments of brain: Implications for neurodevelopmental and neuropsychiatric disorders. Transl Psychiatry 15: 278. https://doi.org/10.1038/s41398-025-03504-2

[4] Kumar M, Gupta S, Kalia K, et al. (2024) Role of phytoconstituents in cancer treatment: A review. Recent Adv Food Nutr Agric 15: 115-137. https://doi.org/10.2174/012772574X274566231220051254

[5] Endale M, Park SC, Kim S, et al. (2013) Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology 218: 1452-1467. https://doi.org/10.1016/j.imbio.2013.04.019

[6] Zoico E, Nori N, Darra E, et al. (2021) Senolytic effects of quercetin in an in vitro model of pre-adipocytes and adipocytes induced senescence. Sci Rep 11: 23237. https://doi.org/10.1038/s41598-021-02544-0

[7] Balasubramanian R, Bazaz MR, Pasam T, et al. (2023) Involvement of microbiome gut-brain axis in neuroprotective effect of quercetin in mouse model of repeated mild traumatic brain injury. Neuromol Med 25: 242-254. https://doi.org/10.1007/s12017-022-08732-z

[8] Carrillo-Martinez EJ, Flores-Hernández FY, Salazar-Montes AM, et al. (2024) Quercetin, a flavonoid with great pharmacological capacity. Molecules 29: 1000. https://doi.org/10.3390/molecules29051000

[9] Kurhaluk N, Kamiński P, Bilski R, et al. (2025) Role of antioxidants in modulating the microbiota-gut-brain axis and their impact on neurodegenerative diseases. Int J Mol Sci 26: 3658. https://doi.org/10.3390/ijms26083658

[10] Day AJ, Gee JM, DuPont MS, et al. (2003) Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: The role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem Pharmacol 65: 1199-1206. https://doi.org/10.1016/S0006-2952(03)00039-X

[11] Chen X, Yin OQP, Zuo Z, et al. (2005) Pharmacokinetics and modeling of quercetin and metabolites. Pharm Res 22: 892-901. https://doi.org/10.1007/s11095-005-4584-1

[12] Almeida AF, Borge GIA, Piskula M, et al. (2018) Bioavailability of quercetin in humans with a focus on interindividual variation. Compr Rev Food Sci Food Saf 17: 714-731. https://doi.org/10.1111/1541-4337.12342

[13] Kasahara K, Kerby RL, Aquino-Martinez R, et al. (2025) Gut microbes modulate the effects of the flavonoid quercetin on atherosclerosis. NPJ Biofilms Microbiomes 11: 12. https://doi.org/10.1038/s41522-024-00626-1

[14] Li K, Nakamura T, Nakamura Y . (2022) Ring fission catabolites of quercetin glycosides. J Environ Sci Sustain Soc 11: MR02_p5-MR02_p8. https://doi.org/10.3107/jesss.11.MR02

[15] Mahdi L, Graziani A, Baffy G, et al. (2025) Unlocking polyphenol efficacy: The role of gut microbiota in modulating bioavailability and health effects. Nutrients 17: 2793. https://doi.org/10.3390/nu17172793

[16] Matsukawa N, Matsumoto M, Hara H (2009) High biliary excretion levels of quercetin metabolites after administration of a quercetin glycoside in conscious bile duct-cannulated rats. Biosci Biotechnol Biochem 73: 1863-1865. https://doi.org/10.1271/bbb.90031

[17] Chalet C, Rubbens J, Tack J, et al. (2018) Intestinal disposition of quercetin and its phase-II metabolites after oral administration in healthy volunteers. J Pharm Pharmacol 70: 1002-1008. https://doi.org/10.1111/jphp.12929

[18] Ishisaka A, Kawabata K, Miki S, et al. (2013) Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages. PloS One 8: e80843. https://doi.org/10.1371/journal.pone.0080843

[19] Williamson G, Clifford MN (2025) A critical examination of human data for the biological activity of quercetin and its phase-2 conjugates. Crit Rev Food Sci Nutr 65: 1669-1705. https://doi.org/10.1080/10408398.2023.2299329

[20] Frenț OD, Stefan L, Morgovan CM, et al. (2024) A systematic review: Quercetin-secondary metabolite of the flavonol class, with multiple health benefits and low bioavailability. Int J Mol Sci 25: 12091. https://doi.org/10.3390/ijms252212091

[21] Majid I, Majid D, Makroo HA, et al. (2024) Enhancing the bioavailability and gut health benefits of quercetin from sprouted onions: A comprehensive review in the context of food-derived bioactives. Food Chem Adv 4: 100725. https://doi.org/10.1016/j.focha.2024.100725

[22] Graefe EU, Wittig JW, Mueller S, et al. (2001) Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41: 492-499. https://doi.org/10.1177/00912700122010366

[23] Ishisaka A, Kawabata K, Miki S, et al. (2013) Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages. PLoS One 8: e80843. https://doi.org/10.1371/journal.pone.0080843

[24] Catalán M, Ferreira J, Carrasco-Pozo C (2020) The microbiota-derived metabolite of quercetin, 3,4-dihydroxyphenylacetic acid prevents malignant transformation and mitochondrial dysfunction induced by hemin in colon cancer and normal colon epithelia cell lines. Molecules 25: 4138. https://doi.org/10.3390/molecules25184138

[25] Wang S, Yao J, Zhou B, et al. (2018) Bacteriostatic effect of quercetin as an antibiotic alternative in vivo and its antibacterial mechanism in vitro. J Food Prot 81: 68-78. https://doi.org/10.4315/0362-028X.JFP-17-214

[26] Roy PK, Song MG, Park SY (2022) The inhibitory effect of quercetin on biofilm formation of Listeria monocytogenes mixed culture and repression of virulence. Antioxidants 11: 1733. https://doi.org/10.3390/antiox11091733

[27] Liu J, Liu Y, Huang C, et al. (2025) Quercetin-driven Akkermansia Muciniphila alleviates obesity by modulating bile acid metabolism via an ILA/m6A/CYP8B1 signaling. Adv Sci 12: e12865. https://doi.org/10.1002/advs.202412865

[28] Zhang Z, Peng X, Li S, et al. (2014) Isolation and identification of quercetin degrading bacteria from human fecal microbes. PLoS One 9: e90531. https://doi.org/10.1371/journal.pone.0090531

[29] Tiwari C, Singh A, Kumar D (2023) Comprehensive characterization and in vitro evaluation of a novel POQCL drug delivery system, Nanosci Nanotechnol Asia 13: e071223224207. https://doi.org/10.2174/0122106812276945231201071629

[30] Meng X, Xia C, Wu H, et al. (2024) Metabolism of quercitrin in the colon and its beneficial regulatory effects on gut microbiota. J Sci Food Agric 104: 9255-9264. https://doi.org/10.1002/jsfa.13747

[31] Lu J, Huang Y, Zhang Y, et al. (2025) Quercetin ameliorates obesity and inflammation via microbial metabolite indole-3-propionic acid in high fat diet-induced obese mice. Front Nutr 12: 1574792. https://doi.org/10.3389/fnut.2025.1574792

[32] Zhu X, Dai X, Zhao L, et al. (2024) Quercetin activates energy expenditure to combat metabolic syndrome through modulating gut microbiota-bile acids crosstalk in mice. Gut Microbes 16: 2390136. https://doi.org/10.1080/19490976.2024.2390136

[33] Xiong M, Kuang W, Liu Z, et al. (2025) Quercetin alleviates ulcerative colitis via regulating gut microbiota and tryptophan metabolism. MSystems 10: e00703-25. https://doi.org/10.1128/msystems.00703-25

[34] Zhou K (2017) Strategies to promote abundance of Akkermansia Muciniphila, an emerging probiotic in the gut: evidence from dietary intervention studies. J Funct Foods 33: 194-201. https://doi.org/10.1016/j.jff.2017.03.045

[35] Li B, Yan Y, Zhang T, et al. (2024) Quercetin reshapes gut microbiota homeostasis and modulates brain metabolic profile to regulate depression-like behaviors induced by CUMS in rats. Front Pharmacol 15: 1362464. https://doi.org/10.3389/fphar.2024.1362464

[36] Mi W, Hu Z, Xu L, et al. (2022) Quercetin positively affects gene expression profiles and metabolic pathway of antibiotic-treated mouse gut microbiota. Front Microbiol 13: 983358. https://doi.org/10.3389/fmicb.2022.983358

[37] Han X, Xu T, Fang Q, et al. (2021) Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy. Redox Biol 44: 102010. https://doi.org/10.1016/j.redox.2021.102010

[38] Yao RQ, Qi DS, Yu HL, et al. (2012) Quercetin attenuates cell apoptosis in focal cerebral ischemia rat brain via activation of BDNF-TrkB-PI3K/Akt signaling pathway. Neurochem Res 37: 2777-2786. https://doi.org/10.1007/s11064-012-0871-5

[39] Yang R, Shen YJ, Chen M, et al. (2022) Quercetin attenuates ischemia reperfusion injury by protecting the blood-brain barrier through Sirt1 in MCAO rats. J Asian Nat Prod Res 24: 278-289. https://doi.org/10.1080/10286020.2021.1949302

[40] Tiwari C, Tomer J, Kumar D (2024) Liposomal drug delivery: Progress, clinical outlook, and ongoing challenges. Recent Adv Drug Deliv Formulation 18: 157-169. https://doi.org/10.2174/0126673878300031240703070511

[41] Zhang HX, Li YY, Liu ZJ, et al. (2022) Quercetin effectively improves LPS-induced intestinal inflammation, pyroptosis, and disruption of the barrier function through the TLR4/NF-κB/NLRP3 signaling pathway in vivo and in vitro. Food Nutr Res 66: 8948. https://doi.org/10.29219/fnr.v66.8948

[42] Longo S, Rizza S, Federici M (2023) Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes. Acta Diabetol 60: 1007-1017. https://doi.org/10.1007/s00592-023-02088-x

[43] Suganya K, Koo BS (2020) Gut-brain axis: Role of gut microbiota on neurological disorders and how probiotics/prebiotics beneficially modulate microbial and immune pathways to improve brain functions. Int J Mol Sci 21: 7551. https://doi.org/10.3390/ijms21207551

[44] Kumar D, Malviya R, Sharma PK, et al. (2020) Advancement in nano pharmaceutical formulations and their biomedical use. Nanosci Nanotechnol 11: 262-269. https://doi.org/10.2174/2210681210999200723165456

[45] Xu J, Li Y, Yang X, et al. (2024) Quercetin inhibited LPS-induced cytokine storm by interacting with the AKT1-FoxO1 and Keap1-Nrf2 signaling pathway in macrophages. Sci Rep 14: 20913. https://doi.org/10.1038/s41598-024-71569-y

[46] Zhao P, Chen Y, Zhou S, et al. (2025) Microbial modulation of tryptophan metabolism links gut microbiota to disease and its treatment. Pharmacol Res 219: 107896. https://doi.org/10.1016/j.phrs.2025.107896

[47] Lin R, Piao M, Song Y . (2019) Dietary quercetin increases colonic microbial diversity and attenuates colitis severity in Citrobacterrodentium-infected mice. Front Microbiol 10: 1092. https://doi.org/10.3389/fmicb.2019.01092

[48] Zhang Y, Yu W, Zhang L, et al. (2022) The interaction of polyphenols and the gut microbiota in neurodegenerative diseases. Nutrients 14: 5373. https://doi.org/10.3390/nu14245373

[49] Filosa S, Di Meo F, Crispi S (2018) Polyphenols-gut microbiota interplay and brain neuromodulation. Neural Regen Res 13: 2055-2059. https://doi.org/10.4103/1673-5374.241429

[50] Silvestro S, Bramanti P, Mazzon E (2021) Role of quercetin in depressive-like behaviors: Findings from animal models. Appl Sci 11: 7116. https://doi.org/10.3390/app11157116

[51] Petra AI, Panagiotidou S, Hatziagelaki E, et al. (2015) Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther 37: 984-995. https://doi.org/10.1016/j.clinthera.2015.04.002

[52] Kumar D, Sharma PK (2023) Wound healing, anti-inflammatory and antioxidant potential of quercetin loaded Banana starch nanoparticles. Anti-inflamm Anti-allergy Agents Med Chem 22: 230-235. https://doi.org/10.2174/0118715230252770231020060606

[53] Mehta I, Juneja K, Nimmakayala T, et al. (2025) Gut microbiota and mental health: A comprehensive review of gut-brain interactions in mood disorders. Cureus 17: e81447. https://doi.org/10.7759/cureus.81447

[54] Manach C, Morand C, Crespy V, et al. (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426: 331-336. https://doi.org/10.1016/S0014-5793(98)00367-6

[55] Mann GE (2014) Nrf2-mediated redox signalling in vascular health and disease. Free Radic Biol Med 75: S1. https://doi.org/10.1016/j.freeradbiomed.2014.10.595

[56] Li C, Zhang WJ, Frei B (2016) Quercetin inhibits LPS-induced adhesion molecule expression and oxidant production in human aortic endothelial cells by p38-mediated Nrf2 activation and antioxidant enzyme induction. Redox Biol 9: 104-113. https://doi.org/10.1016/j.redox.2016.06.006

[57] Mullen W, Edwards CA, Crozier A (2006) Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 96: 107-116. https://doi.org/10.1079/BJN20061809

[58] Liu J, Zhang ZZ, Yu GR, et al. (2025) Quercetin targets HSP90α and regulates Keap1/Nrf2 pathway to inhibit crosstalk between apoptosis and ferroptosis in oxidatively stressed neurons. J Biochem Mol Toxicol 39: e70583. https://doi.org/10.1002/jbt.70583

[59] Singh NK, Garabadu D . (2021) Quercetin exhibits α7nAChR/Nrf2/HO-1-mediated neuroprotection against STZ-induced mitochondrial toxicity and cognitive impairments in experimental rodents. Neurotox Res 39: 1859-1879. https://doi.org/10.1007/s12640-021-00410-5

[60] Wu J, Lv T, Liu Y, et al. (2024) The role of quercetin in NLRP3-associated inflammation. Inflammopharmacology 32: 3585-3610. https://doi.org/10.1007/s10787-024-01566-0

[61] Hu T, Lu XY, Shi JJ, et al. (2020) Quercetin protects against diabetic encephalopathy via SIRT1/NLRP3 pathway in db/db mice. J Cell Mol Med 24: 3449-3459. https://doi.org/10.1111/jcmm.15026

[62] Adnan M, Siddiqui AJ, Bardakci F, et al. (2025) Neuroprotective potential of quercetin in Alzheimer’s disease: Targeting oxidative stress, mitochondrial dysfunction, and amyloid-β aggregation. Front Pharmacol 16: 1593264. https://doi.org/10.3389/fphar.2025.1593264

[63] Li Y, Man M, Tian Y, et al. (2025) Quercetin protects against neuronal toxicity by activating the PI3K/Akt/GSK-3β pathway in in vivo models of MPTP-induced Parkinson’s disease. Inflammopharmacology 33: 4063-4076. https://doi.org/10.1007/s10787-025-01712-2

[64] Perrone P, D’Angelo S (2025) Hormesis and health: Molecular mechanisms and the key role of polyphenols. Food Chem Adv 7: 101030. https://doi.org/10.1016/j.focha.2025.101030

[65] Calabrese EJ, Hayes AW, Pressman P, et al. (2024) Quercetin induces its chemoprotective effects via hormesis. Food Chem Toxicol 184: 114419. https://doi.org/10.1016/j.fct.2023.114419

[66] Fiore M, Tonchev AB, Pancheva RZ, et al. (2025) Increasing life expectancy with plant polyphenols: Lessons from the Mediterranean and Japanese diets. Molecules 30: 2888. https://doi.org/10.3390/molecules30132888

[67] Skaperda Z, Tekos F, Vardakas P, et al. (2021) Reconceptualization of hormetic responses in the frame of redox toxicology. Int J Mol Sci 23: 49. https://doi.org/10.3390/ijms23010049

[68] Ma ZX, Zhang RY, Rui WJ, et al. (2021) Quercetin alleviates chronic unpredictable mild stress-induced depressive-like behaviors by promoting adult hippocampal neurogenesis via FoxG1/CREB/BDNF signaling pathway. Behav Brain Res 408: 113245. https://doi.org/10.1016/j.bbr.2021.113245

[69] Cai YT, Chen DN, Li KX, et al. (2025) Quercetin inhibited chronic unpredictable mild stress-induced mouse depressive behaviors through attenuating lateral habenula neuronal activities. Metab Brain Dis 40: 149. https://doi.org/10.1007/s11011-025-01569-y

[70] Samad N, Saleem A, Yasmin F, et al. (2018) Quercetin protects against stress-induced anxiety- and depression-like behavior and improves memory in male mice. Physiol Res 67: 795-808. https://doi.org/10.33549/physiolres.933776

[71] Sabogal-Guáqueta AM, Muñoz-Manco JI, Ramírez-Pineda JR, et al. (2015) The flavonoid quercetin ameliorates Alzheimer’s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer’s disease model mice. Neuropharmacology 93: 134-145. https://doi.org/10.1016/j.neuropharm.2015.01.027

[72] Costa LG, Garrick JM, Roquè PJ, et al. (2016) Mechanisms of neuroprotection by quercetin: Counteracting oxidative stress and more. Oxid Med Cell Longev 2016: 2986796. https://doi.org/10.1155/2016/2986796

[73] Savino R, Medoro A, Ali S, et al. (2023) The emerging role of flavonoids in autism spectrum disorder: A systematic review. J Clin Med 12: 3520. https://doi.org/10.3390/jcm12103520

[74] Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7: 27-31.

[75] Zhang XW, Chen JY, Ouyang D, et al. (2020) Quercetin in animal models of Alzheimer’s disease: A systematic review of preclinical studies. Int J Mol Sci 21: 493. https://doi.org/10.3390/ijms21020493

[76] Lasure VU, Singh Gautam A, Singh RK (2024) Quercetin ameliorates neuroinflammatory and neurodegenerative biomarkers in the brain and improves neurobehavioral parameters in a repeated intranasal amyloid-beta exposed model of Alzheimer’s disease. Food Funct 15: 8712-8728. https://doi.org/10.1039/d4fo02602k

[77] Graefe EU, Derendorf H, Veit M (1999) Pharmacokinetics and bioavailability of the flavonol quercetin in humans. Int J Clin Pharm Ther 37: 219-233.

[78] Mohos V, Fliszár-Nyúl E, Ungvári O, et al. (2020) Inhibitory effects of quercetin and its main methyl, sulfate, and glucuronic acid conjugates on cytochrome P450 enzymes, and on OATP, BCRP and MRP2 transporters. Nutrients 12: 2306. https://doi.org/10.3390/nu12082306

[79] Riva A, Ronchi M, Petrangolini G, et al. (2019) Improved oral absorption of quercetin from Quercetin Phytosome®, a new delivery system based on food-grade lecithin. Eur J Drug Metab Pharmacokinet 44: 169-177. https://doi.org/10.1007/s13318-018-0517-3

[80] Choi JS, Piao YJ, Kang KW (2011) Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin. Arch Pharm Res 34: 607-613. https://doi.org/10.1007/s12272-011-0411-x

[81] Mohos V, Fliszár-Nyúl E, Ungvári O, et al. (2020) Inhibitory effects of quercetin and its main methyl, sulfate, and glucuronic acid conjugates on cytochrome P450 enzymes, and on OATP, BCRP and MRP2 transporters. Nutrients 12: 2306. https://doi.org/10.3390/nu12082306

[82] Kumar D, Sharma PK (2023) Formulation and evaluation of Quercetin-loaded banana starch nanoparticles, Nanoscience Nanotechnol Asia 13: e240523217291. https://doi.org/10.2174/2210681213666230524145559

[83] Liu L, Barber E, Kellow NJ, et al. (2025) Improving quercetin bioavailability: A systematic review and meta-analysis of human intervention studies. Food Chem 477: 143630. https://doi.org/10.1016/j.foodchem.2025.143630

[84] Li H, Li M, Fu J, et al. (2021) Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions. Drug Deliv 28: 1226-1236. https://doi.org/10.1080/10717544.2021.1927244

[85] Ou Q, Zheng Z, Zhao Y, Lin W (2020) Impact of quercetin on systemic levels of inflammation: A meta-analysis of randomised controlled human trials. Int J Food Sci Nutr 71: 152-163. https://doi.org/10.1080/09637486.2019.1627515

[86] Almeida AF, Borge GIA, Piskula M, et al. (2018) Bioavailability of Quercetin in Humans with a Focus on Interindividual Variation. Compr Rev Food Sci Food Saf 17: 714-731. https://doi.org/10.1111/1541-4337.12342

[87] Yang J, Song X, Yan S, et al. (2026) The gut microbiota influences neurodegenerative diseases through the gut-brain axis: Molecular mechanisms and effects on immune function. Front Immunol 16: 1739329. https://doi.org/10.3389/fimmu.2025.1739329

[88] Chen YQ, Chen HY, Tang QQ, et al. (2022) Protective effect of quercetin on kidney diseases: From chemistry to herbal medicines. Front. Pharmacol 13: 968226. https://doi.org/10.3389/fphar.2022.968226

[89] Tamura M, Hoshi C, Kobori M, et al. (2017) Quercetin metabolism by fecal microbiota from healthy elderly human subjects. PLoS One 12: e0188271. https://doi.org/10.1371/journal.pone.0188271

[90] Jia C, Zhu W, Yuan Y, et al. (2026) How gut microbiota contribute to neuropsychiatric disorders: Evidence from neuroimaging studies. Front Microbiol 17: 1760096. https://doi.org/10.3389/fmicb.2026.1760096

[91] Alharbi HOA, Alshebremi M, Babiker AY, et al. (2025) The role of quercetin, a flavonoid in the management of pathogenesis through regulation of oxidative stress, inflammation, and biological activities. Biomolecules 15: 151. https://doi.org/10.3390/biom15010151

[92] KumarM, KumarD (2025) Formulation and evaluation of quercetin loaded sago starch nanoparticles, Curr Nanomed 15: 637-645. https://doi.org/10.2174/0124681873299675240628125625